RSS Items

The company is set to become the first $1tn drugmaker, but investors see warning signs it has reached ‘peak enthusiasm’

Sales figures for Mounjaro and Zepbound spook investors in world’s biggest drugmaker

Point is developing radioligand molecules that can deliver targeted radiation to tumour cells

Drug company made claims even though a study of donanemab’s preventive potential is not due to end until 2027

Cheaper valuations have finally drawn back cash-rich pharmaceutical makers

Mounjaro has achieved 22.5 per cent loss of body weight in trials

A new generation is finding brilliant and creative ways to object to the arrest of mayor Ekrem İmamoğlu

Probe of Luis Hermosilla, who advised ministers and business leaders, has already ensnared several officials